Life Sciences

Biotechnology Cell Biology Genetics Molecular Biology Microbiology Biology Immunology Research Astrobiology Origin of Life

4 ARTICLES

yesterday

AstraZeneca Opens $1 Billion R&D Centre in Kendall Square

Equipped with robotics, continuous automation and agentic AI to accelerate drug discovery, the 18‑storey facility expands AstraZeneca’s Cambridge research capacity.

3 ARTICLES

yesterday

Karl‑Anthony Towns Partners With Sanofi to Promote Updated NUVAXOVID Shot

3 ARTICLES

yesterday

Scientists Log 57 New Species and Five New Genera From South Atlantic Deep-Sea Canyon

5 ARTICLES

3w ago

Journal and University Open Investigations After Child’s Death Linked to Brain-Targeted Gene Editing

6 ARTICLES

2mo ago

GSK to Close Stevenage Hub and Build £400m Cambridge R&D Centre

10 ARTICLES

2mo ago

Bristol Myers Squibb Buys Second NVIDIA DGX SuperPOD Built on Vera Rubin

5 ARTICLES

2mo ago

Scientists Detect Erythrulose Sugar in Cloud Near Milky Way Centre

3 ARTICLES

2mo ago

Celtarys Launches Fluorescent Kit to Replace Radioactive Preclinical Assays

19 ARTICLES

3mo ago

Perseverance Detects Complex Organic Carbon in Jezero Mudstones

8 ARTICLES

3mo ago

NVIDIA Launches BioNeMo Agent Toolkit for Agentic Life‑Sciences Workflows

3 ARTICLES

3mo ago

Insilico and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal for Neuroimmune Therapies

4 ARTICLES

3mo ago

Dubai Creates Authority to Drive Healthy Longevity

3 ARTICLES

3mo ago

Samsung Becomes Largest Shareholder in Element Biosciences With $175 Million Stake

3 ARTICLES

4mo ago

Immuneel Raises ₹100 Crore Series B to Scale CAR‑T Manufacturing

3 ARTICLES

4mo ago

OpenAI Upgrades GPT‑Rosalind for Biodefense and Life‑Sciences Work

5 ARTICLES

4mo ago

Verily Asks EPA to Permit Wolbachia Male‑Mosquito Trials in Florida and California

4 ARTICLES

4mo ago

OpenAI Launches Rosalind Biodefense Program and GPT‑Rosalind Model

Life Sciences

AstraZeneca Opens $1 Billion R&D Centre in Kendall Square

Karl‑Anthony Towns Partners With Sanofi to Promote Updated NUVAXOVID Shot

Scientists Log 57 New Species and Five New Genera From South Atlantic Deep-Sea Canyon

Recombinant Nanobody Antivenom Neutralizes Indian Cobra Venoms in Mice

SandboxAQ Releases AQPotency and AQCat for Faster Drug and Catalyst Discovery

Anthropic’s Claude Reports 27% Hit Rate Designing De Novo Protein Binders

Journal and University Open Investigations After Child’s Death Linked to Brain-Targeted Gene Editing

GSK to Close Stevenage Hub and Build £400m Cambridge R&D Centre

Bristol Myers Squibb Buys Second NVIDIA DGX SuperPOD Built on Vera Rubin

Scientists Detect Erythrulose Sugar in Cloud Near Milky Way Centre

Never miss stories about

Life Sciences

Celtarys Launches Fluorescent Kit to Replace Radioactive Preclinical Assays

Perseverance Detects Complex Organic Carbon in Jezero Mudstones

NVIDIA Launches BioNeMo Agent Toolkit for Agentic Life‑Sciences Workflows

Insilico and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal for Neuroimmune Therapies

Dubai Creates Authority to Drive Healthy Longevity

Samsung Becomes Largest Shareholder in Element Biosciences With $175 Million Stake

Immuneel Raises ₹100 Crore Series B to Scale CAR‑T Manufacturing

OpenAI Upgrades GPT‑Rosalind for Biodefense and Life‑Sciences Work

Verily Asks EPA to Permit Wolbachia Male‑Mosquito Trials in Florida and California

OpenAI Launches Rosalind Biodefense Program and GPT‑Rosalind Model

Never miss stories about

Life Sciences